These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2868903)

  • 1. Some atypical neuroleptics inhibit [3H]SCH 23390 binding in vivo.
    Andersen PH; Nielsen EB; Grønvald FC; Braestrup C
    Eur J Pharmacol; 1986 Jan; 120(1):143-4. PubMed ID: 2868903
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific binding of 3H-SCH 23390 to dopamine D1 receptors in vivo.
    Andersen PH; Grønvald FC
    Life Sci; 1986 Apr; 38(16):1507-14. PubMed ID: 2871467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the pharmacological characteristics of [3H]raclopride and [3H]SCH 23390 binding to dopamine receptors in vivo in mouse brain.
    Andersen PH
    Eur J Pharmacol; 1988 Jan; 146(1):113-20. PubMed ID: 2895008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of [3H]SCH 23390 to D-1 receptors in the putamen of control and parkinsonian subjects.
    Raisman R; Cash R; Ruberg M; Javoy-Agid F; Agid Y
    Eur J Pharmacol; 1985 Jul; 113(3):467-8. PubMed ID: 2864270
    [No Abstract]   [Full Text] [Related]  

  • 5. Binding of [3H]SCH 23390 to dopamine D-1 receptors in rat retina in vitro.
    Gredal O; Parkinson D; Nielsen M
    Eur J Pharmacol; 1987 Jun; 137(2-3):241-5. PubMed ID: 2886353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390.
    O'Boyle KM; Waddington JL
    Eur J Pharmacol; 1984 Mar; 98(3-4):433-6. PubMed ID: 6144559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of [125I]SCH 23982 binding in human brain: comparison with [3H]SCH 23390.
    Laruelle M; Sidhu A; Casanova MF; Weinberger DR; Kleinman JE
    Neurosci Lett; 1991 Oct; 131(2):273-6. PubMed ID: 1837073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chronic methamphetamine treatment on the binding parameters of [3H]SCH 23390, a selective D1-dopamine receptor ligand, in the rat brain.
    Nonaka R; Moroji T
    Neurosci Lett; 1990 Nov; 120(1):109-12. PubMed ID: 2149876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain.
    Seeman P; Niznik HB; Guan HC; Booth G; Ulpian C
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10156-60. PubMed ID: 2574862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and behavioral studies of D1 dopamine receptors utilizing SCH 23390.
    Hess EJ; Creese I
    Adv Exp Med Biol; 1986; 204():29-52. PubMed ID: 2878579
    [No Abstract]   [Full Text] [Related]  

  • 11. Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatum.
    Hess EJ; Battaglia G; Norman AB; Iorio LC; Creese I
    Eur J Pharmacol; 1986 Feb; 121(1):31-8. PubMed ID: 2869957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390.
    Savasta M; Dubois A; Scatton B
    Brain Res; 1986 Jun; 375(2):291-301. PubMed ID: 2942221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The inhibition of dopamine D1 and D2 receptors in human putamen by antipsychotic drugs].
    Kobayashi T; Shimizu H; Toru M
    Yakubutsu Seishin Kodo; 1990 Jun; 10(2):331-4. PubMed ID: 1979198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH; Dvorkin B
    Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of EEDQ on the dopamine D-1 receptor in vivo and in vitro.
    Andersen PH
    Eur J Pharmacol; 1988 Jul; 152(1-2):153-6. PubMed ID: 2905267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [3H]SCH 23390 labeled D1 dopamine receptors are unchanged in schizophrenia and Parkinson's disease.
    Pimoule C; Schoemaker H; Reynolds GP; Langer SZ
    Eur J Pharmacol; 1985 Aug; 114(2):235-7. PubMed ID: 2864273
    [No Abstract]   [Full Text] [Related]  

  • 17. Interaction of flunarizine with dopamine D2 and D1 receptors.
    Ambrosio C; Stefanini E
    Eur J Pharmacol; 1991 May; 197(2-3):221-3. PubMed ID: 1833208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of binding of 3H-SCH-23390 to D-1 dopaminergic receptor sites in rat striatal tissue.
    Faedda G; Kula NS; Baldessarini RJ
    Biochem Pharmacol; 1989 Feb; 38(3):473-80. PubMed ID: 2563653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The kinetics of [3H]SCH 23390 dissociation from rat striatal dopamine D1 receptors: effect of dopamine.
    Farrell CB; O'Boyle KM
    Eur J Pharmacol; 1994 Jun; 268(1):79-88. PubMed ID: 7925614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential localization of dopamine D1 and D2 receptors in rat retina.
    Tran VT; Dickman M
    Invest Ophthalmol Vis Sci; 1992 Apr; 33(5):1620-6. PubMed ID: 1532792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.